# FDA Inspection 1022660 - Labcorp Drug Development - July 26, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/labcorp-drug-development/e3ea5cc5-e814-41aa-8d1a-50ac5c183d65
Source feed: FDA_Inspections

> FDA Inspection 1022660 for Labcorp Drug Development on July 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1022660
- Company Name: Labcorp Drug Development
- Inspection Date: 2017-07-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1168630 - 2022-04-25](https://www.globalkeysolutions.net/records/fda_inspections/labcorp-drug-development/a50d857a-14b9-4f79-ab98-34070136da78)
- [FDA Inspection 1147393 - 2021-06-17](https://www.globalkeysolutions.net/records/fda_inspections/labcorp-drug-development/0660c639-f996-40ed-a7c4-41507f3a7f5f)
- [FDA Inspection 1123056 - 2020-03-05](https://www.globalkeysolutions.net/records/fda_inspections/labcorp-drug-development/b4c73c10-591a-47ac-8e22-9d13a38e3f9b)
- [FDA Inspection 1064469 - 2018-07-19](https://www.globalkeysolutions.net/records/fda_inspections/labcorp-drug-development/c78bb744-2d8a-40c2-8327-03479ad282f0)
- [FDA Inspection 790402 - 2012-07-13](https://www.globalkeysolutions.net/records/fda_inspections/labcorp-drug-development/49d72429-c105-423a-9ee9-63abd8871601)

Company: https://www.globalkeysolutions.net/companies/labcorp-drug-development/590644d8-047e-4701-b6f2-fcb4b881a7a1

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c